Playground Global, a16z back $26M seed for RNA editing startup aiming to address multiple mutations with single shot

Amber Tong

The advent of CRISPR technologies for gene editing has opened up the possibility of treating genetic disorders by making precise changes to patients’ DNA or …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Playground Global, a16z back $26M seed for RNA editing startup aiming to address multiple mutations with single shot

Amber Tong

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Regeneron plans to buy 23andMe for $256M

David Liu, Sam Sternberg unveil new way to insert big genes in human cells

Prime Medicine sidelines only clinical program, replaces CEO and lays off some staff

Intellia's CRISPR therapy likely causes 'permanent' gene knockdown in ATTR amyloidosis

Exclusive: CellCentric collects $120M to treat multiple myeloma with a capsule

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?

Play­ground Glob­al, a16z back $26M seed for RNA edit­ing start­up aim­ing to ad­dress mul­ti­ple mu­ta­tions with sin­gle shot

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Playground Global, a16z back $26M seed for RNA editing startup aiming to address multiple mutations with single shot